Form 8-K PTC THERAPEUTICS, INC. For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
PTC Therapeutics (PTCT) Tops Q2 EPS by 13c; Offers FY16 Outlook
August 4, 2016 5:10 PM EDTPTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($1.14), $0.13 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.68 million.
2016 Guidance:
Total ex-U.S. Translarna nmDMD revenues for 2016 are anticipated to... More